Ovizio

Brussels, Belgium Founded: 2009 • Age: 17 yrs
Imaging systems and AI software for microscopes are developed.
Request Access

About Ovizio

Ovizio is a company based in Brussels (Belgium) founded in 2009.. Ovizio has raised $9.1 million across 5 funding rounds from investors including European Union, EIC Fund and New Science Ventures. The company has 16 employees as of December 31, 2022. Ovizio offers products and services including iLINE-F and BioConnect. Ovizio operates in a competitive market with competitors including PathAI, Deepcell, Aignostics, Pictor Labs and Neko Health, among others.

  • Headquarter Brussels, Belgium
  • Employees 16 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Ovizio Imaging Systems
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
    $-3.58 M (USD)
    -57
    as on Dec 31, 2022
  • EBITDA
    $-2.3 M (USD)
    -124
    as on Dec 31, 2022
  • Total Equity Funding
    $9.1 M (USD)

    in 5 rounds

  • Latest Funding Round
    $57.05 K (USD), Grant

    Jun 30, 2017

  • Investors
  • Employee Count
    16

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Ovizio

Ovizio offers a comprehensive portfolio of products and services, including iLINE-F and BioConnect. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Analyzes cells in real-time for bioprocessing without labeling.

Facilitates sampling from culture vessels for continuous monitoring.

Funding Insights of Ovizio

Ovizio has successfully raised a total of $9.1M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $57.05 thousand completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Grant — $57,046
  • First Round
  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2017 Amount Grant - Ovizio Valuation

investors

Jan, 2017 Amount Grant - Ovizio Valuation

investors

Jan, 2016 Amount Grant - Ovizio Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Ovizio

Ovizio has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, EIC Fund and New Science Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Early, mid, and late-stage investments are made in science sectors.
Founded Year Domain Location
Venture capital fund investing in technological breakthroughs from universities.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Ovizio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Ovizio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ovizio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Ovizio

Ovizio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Deepcell, Aignostics, Pictor Labs and Neko Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
domain founded_year HQ Location
AI-powered single cell classification and isolation technology for clinical research
domain founded_year HQ Location
AI-based pathology diagnostic software is provided for medical analysis.
domain founded_year HQ Location
AI-based tools for pathological image analysis are provided to labs.
domain founded_year HQ Location
Platform offering solutions for preventive health scans
domain founded_year HQ Location
Miniscope platforms are developed for decoding brain neural circuits.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ovizio

Frequently Asked Questions about Ovizio

When was Ovizio founded?

Ovizio was founded in 2009.

Where is Ovizio located?

Ovizio is headquartered in Brussels, Belgium. It is registered at Brussels, Brussels-capital Region, Belgium.

Is Ovizio a funded company?

Ovizio is a funded company, having raised a total of $9.1M across 5 funding rounds to date. The company's 1st funding round was a Grant of $728.7K, raised on Jun 01, 2009.

How many employees does Ovizio have?

As of Dec 31, 2022, the latest employee count at Ovizio is 16.

What does Ovizio do?

Ovizio was founded in 2009 in Brussels, Belgium, and operates in the microscopy and imaging sector. Machine-learning software, including the AI-based OsOne for 3D image analysis and continuous data recording, is developed by the company. Microscopic products such as the iLine F, QMode, and iLine engineering platform are also produced to support advanced imaging applications.

Who are the top competitors of Ovizio?

Ovizio's top competitors include Aignostics, Pictor Labs and PathAI.

What products or services does Ovizio offer?

Ovizio offers iLINE-F and BioConnect.

Who are Ovizio's investors?

Ovizio has 7 investors. Key investors include European Union, EIC Fund, New Science Ventures, Qbic Venture Partners, and Nausicaa Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available